322 related articles for article (PubMed ID: 30138683)
1. Temporal Trend in Incidental Prostate Cancer Detection at Surgery for Benign Prostatic Hyperplasia.
Capogrosso P; Capitanio U; Vertosick EA; Ventimiglia E; Chierigo F; Oreggia D; Moretti D; Briganti A; Vickers AJ; Montorsi F; Salonia A
Urology; 2018 Dec; 122():152-157. PubMed ID: 30138683
[TBL] [Abstract][Full Text] [Related]
2. "Finding the needle in a haystack": oncologic evaluation of patients treated for LUTS with holmium laser enucleation of the prostate (HoLEP) versus transurethral resection of the prostate (TURP).
Herlemann A; Wegner K; Roosen A; Buchner A; Weinhold P; Bachmann A; Stief CG; Gratzke C; Magistro G
World J Urol; 2017 Nov; 35(11):1777-1782. PubMed ID: 28516315
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of prostate cancer between holmium laser enucleation of the prostate and transurethral resection of the prostate for benign prostatic hyperplasia: A retrospective comparative study.
He G; Sun C; Shu Y; Wang B; Du C; Chen J; Wen J
Int J Surg; 2020 Jul; 79():217-221. PubMed ID: 32447004
[TBL] [Abstract][Full Text] [Related]
4. "In-bore" MRI prostate biopsy is a safe preoperative clinical tool to exclude significant prostate cancer in symptomatic patients with benign prostatic obstruction before transurethral laser enucleation.
Porreca A; D'Agostino D; Vigo M; Corsi P; Romagnoli D; Del Rosso A; Schiavina R; Brunocilla E; Artibani W; Giampaoli M
Arch Ital Urol Androl; 2020 Jan; 91(4):224-229. PubMed ID: 31937084
[TBL] [Abstract][Full Text] [Related]
5. Comorbidities as predictors of incidental prostate cancer after Holmium laser enucleation of the prostate: diabetes and high-risk cancer.
Ohwaki K; Endo F; Shimbo M; Fujisaki A; Hattori K
Aging Male; 2017 Dec; 20(4):257-260. PubMed ID: 28332895
[TBL] [Abstract][Full Text] [Related]
6. Significance of prostate-specific antigen-related factors in incidental prostate cancer treated by holmium laser enucleation of the prostate.
Otsubo S; Yokomizo A; Mochida O; Shiota M; Tatsugami K; Inokuchi J; Naito S
World J Urol; 2015 Mar; 33(3):329-33. PubMed ID: 24804843
[TBL] [Abstract][Full Text] [Related]
7. Coexisting prostate cancer found at the time of holmium laser enucleation of the prostate for benign prostatic hyperplasia: predicting its presence and grade in analyzed tissue.
Bhojani N; Boris RS; Monn MF; Mandeville JA; Lingeman JE
J Endourol; 2015 Jan; 29(1):41-6. PubMed ID: 25046691
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
Elshal AM; Elmansy HM; Elhilali MM
BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and risk factors of incidental prostate cancer in certain surgeries for benign prostatic hyperplasia: A systematic review and meta-analysis.
Guo Z; He J; Huang L; Wang Z; Hu P; Wang S; Bai Z; Pan J
Int Braz J Urol; 2022; 48(6):915-929. PubMed ID: 35195386
[TBL] [Abstract][Full Text] [Related]
10. Incidental Prostate Cancer Diagnosis Is Common After Holmium Laser Enucleation of the Prostate.
Sakai A; Borza T; Antar A; Richmond E; Allen GO; Knoedler M; Manakas C; Huang W; Gralnek D; Grimes MD
Urology; 2024 Jan; 183():170-175. PubMed ID: 38043905
[TBL] [Abstract][Full Text] [Related]
11. Incidental prostate cancer revisited: early outcomes after holmium laser enucleation of the prostate.
Nunez R; Hurd KJ; Noble BN; Castle EP; Andrews PE; Humphreys MR
Int J Urol; 2011 Jul; 18(7):543-7. PubMed ID: 21592233
[TBL] [Abstract][Full Text] [Related]
12. HoLEP provides a higher prostate cancer detection rate compared to bipolar TURP: a matched-pair analysis.
Rosenhammer B; Lausenmeyer EM; Mayr R; Burger M; Eichelberg C
World J Urol; 2018 Dec; 36(12):2035-2041. PubMed ID: 29858700
[TBL] [Abstract][Full Text] [Related]
13. Holmium laser enucleation of the prostate for persistent lower urinary tract symptoms after prior benign prostatic hyperplasia surgery.
Jaeger CD; Krambeck AE
Urology; 2013 May; 81(5):1025-9. PubMed ID: 23465142
[TBL] [Abstract][Full Text] [Related]
14. The clinicopathologic patterns of prostatic diseases and prostate cancer in Saudi patients.
Mosli HA; Abdel-Meguid TA; Al-Maghrabi JA; Kamal WK; Saadah HA; Farsi HM
Saudi Med J; 2009 Nov; 30(11):1439-43. PubMed ID: 19882057
[TBL] [Abstract][Full Text] [Related]
15. Detection rate and variables associated with incidental prostate cancer by holmium laser enucleation of the prostate.
Banno T; Nakamura K; Kaneda Y; Ozaki A; Kouchi Y; Ohira T; Shimmura H
Int J Urol; 2022 Aug; 29(8):860-865. PubMed ID: 35584916
[TBL] [Abstract][Full Text] [Related]
16. Holmium laser enucleation of the prostate and perioperative diagnosis of prostate cancer: an outcomes analysis.
Rivera ME; Frank I; Viers BR; Rangel LJ; Krambeck AE
J Endourol; 2014 Jun; 28(6):699-703. PubMed ID: 24484284
[TBL] [Abstract][Full Text] [Related]
17. Holmium Laser Enucleation of the Prostate Provides Similar Incidental Prostate Cancer Detection Rates as Open Prostatectomy: A Matched Pair Analysis.
Rosenhammer B; Lausenmeyer EM; Mayr R; Burger M; Eichelberg C
Urol Int; 2018; 101(4):382-386. PubMed ID: 30235460
[TBL] [Abstract][Full Text] [Related]
18. Changes in serum PSA after endoscopic enucleation of the prostate are predictive for the future diagnosis of prostate cancer.
Lambert E; Goossens M; Palagonia E; Vollemaere J; Mazzone E; Dell'Oglio P; Pauwels E; De Groote R; D'Hondt F; Mottrie A; De Naeyer G; Schatteman P
World J Urol; 2021 Jul; 39(7):2621-2626. PubMed ID: 32997261
[TBL] [Abstract][Full Text] [Related]
19. Incidental prostate cancer after holmium laser enucleation of the prostate-A narrative review.
Yilmaz M; Toprak T; Suarez-Ibarrola R; Sigle A; Gratzke C; Miernik A
Andrologia; 2022 Apr; 54(3):e14332. PubMed ID: 34837229
[TBL] [Abstract][Full Text] [Related]
20. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
